Synlogic, Inc. (SYBX) stock
SYBXOTCPharmaceutical PreparationsFiscal year ends December 31
$1.07+0.07 (+7.00%)
Close on Oct 19, 2026Market cap $13.29MP/E –Yield –
Synlogic total assets
Total assets on the balance sheet at the end of each period.
Synlogic's total assets was $11.85M at Sep 30, 2026. For fiscal 2025 it was $15.45M, down 22.1% from the year before. Over ten years it grew -16.2% a year on average. The highest annual figure on record is $188.57M in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.45M | -22.1% |
| FY2024 | Dec 31, 2024 | $19.83M | -73.8% |
| FY2023 | Dec 31, 2023 | $75.55M | -31.9% |
| FY2022 | Dec 31, 2022 | $110.87M | -36.6% |
| FY2021 | Dec 31, 2021 | $174.74M | +21.5% |
| FY2020 | Dec 31, 2020 | $143.84M | -23.7% |
| FY2019 | Dec 31, 2019 | $188.57M | +34.4% |
| FY2018 | Dec 31, 2018 | $140.34M | +40.8% |
| FY2017 | Dec 31, 2017 | $99.70M | +397.5% |
| FY2016 | Dec 31, 2016 | $20.04M | -78.0% |
| FY2015 | Dec 31, 2015 | $90.92M | +825.4% |
| FY2014 | Dec 31, 2014 | $9.83M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $11.85M | -28.4% |
| Q2 FY2026 | Jun 30, 2026 | $13.48M | -22.4% |
| Q1 FY2026 | Mar 31, 2026 | $14.61M | -18.7% |
| Q4 FY2025 | Dec 31, 2025 | $15.45M | -22.1% |
| Q3 FY2025 | Sep 30, 2025 | $16.56M | -20.2% |
| Q2 FY2025 | Jun 30, 2025 | $17.37M | -19.7% |
| Q1 FY2025 | Mar 31, 2025 | $17.97M | -50.2% |
| Q4 FY2024 | Dec 31, 2024 | $19.83M | -73.8% |
| Q3 FY2024 | Sep 30, 2024 | $20.76M | -68.7% |
| Q2 FY2024 | Jun 30, 2024 | $21.64M | -72.7% |
| Q1 FY2024 | Mar 31, 2024 | $36.06M | -61.4% |
| Q4 FY2023 | Dec 31, 2023 | $75.55M | -31.9% |
| Q3 FY2023 | Sep 30, 2023 | $66.25M | -48.3% |
| Q2 FY2023 | Jun 30, 2023 | $79.28M | -44.8% |
| Q1 FY2023 | Mar 31, 2023 | $93.44M | -41.3% |
| Q4 FY2022 | Dec 31, 2022 | $110.87M | -36.6% |
| Q3 FY2022 | Sep 30, 2022 | $128.24M | -32.7% |
| Q2 FY2022 | Jun 30, 2022 | $143.55M | -8.5% |
| Q1 FY2022 | Mar 31, 2022 | $159.31M | +17.4% |
| Q4 FY2021 | Dec 31, 2021 | $174.74M | +21.5% |
| Q3 FY2021 | Sep 30, 2021 | $190.54M | +28.4% |
| Q2 FY2021 | Jun 30, 2021 | $156.88M | -1.6% |
| Q1 FY2021 | Mar 31, 2021 | $135.75M | -20.7% |
| Q4 FY2020 | Dec 31, 2020 | $143.84M | -23.7% |
| Q3 FY2020 | Sep 30, 2020 | $148.35M | -26.7% |
| Q2 FY2020 | Jun 30, 2020 | $159.39M | -25.8% |
| Q1 FY2020 | Mar 31, 2020 | $171.14M | +18.0% |
| Q4 FY2019 | Dec 31, 2019 | $188.57M | +34.4% |
| Q3 FY2019 | Sep 30, 2019 | $202.41M | +33.1% |
| Q2 FY2019 | Jun 30, 2019 | $214.95M | +33.4% |
| Q1 FY2019 | Mar 31, 2019 | $145.00M | +1.6% |
| Q4 FY2018 | Dec 31, 2018 | $140.34M | +40.8% |
| Q3 FY2018 | Sep 30, 2018 | $152.05M | +45.5% |
| Q2 FY2018 | Jun 30, 2018 | $161.07M | +234.7% |
| Q1 FY2018 | Mar 31, 2018 | $142.66M | +135.4% |
| Q4 FY2017 | Dec 31, 2017 | $99.70M | +397.5% |
| Q3 FY2017 | Sep 30, 2017 | $104.47M | – |
| Q2 FY2017 | Jun 30, 2017 | $48.12M | – |
| Q1 FY2017 | Mar 31, 2017 | $60.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $20.04M | – |
See a number that looks wrong?